Pfizer Japan to Bring New OTC Nasal Spray to Market

Pfizer Japan to Bring New OTC Nasal Spray to Market

Tokyo (JCNN) - Pfizer Japan has announced that it will put on sale Aneton Cor-Tyzine, an OTC nasal spary, on November 9.

Based on four medicinal constituents such as tetrahydrozoline hydrochloride and chlorpheniramine maleate, this new slightly acid solution (spray) helps alleviate allergic rhinitis symptoms as typified by runny and stuffy noses.

A 15 ml-bottle is available at 880yen.

Copyright(C) 2004 Japan Corporate News Network. www.japancorp.net All rights reserved.

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright © 1997-2008 - BioPortfolio Limited.